Combination Antibiotic Therapy Lowers Mortality among Severely III Patients with Pneumococcal Bacteremia

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 4, 2004, Pages 440-444

  Baddour, Larry M ^q   Yu, Victor L ^r,s   Klugman, Keith P ⁱ   Feldman, Charles ⁱ   Ortqvist, Ake ^k   Rello, Jordi ^j   Morris, Arthur J ^h   Luna, Carlos M ^a   Snydman, David R ^o   Wen, Chien Ko ^m   Chedid, M Bernadete F ^c   Hui, David S ^g   Andremont, Antoine ^f   Chiou, Christine C C ^d   Mosquera, Ricardo ^a   De Mier, Carmen ^a   Famiglietti, Angela ^a   Vay, Carlos ^a   Gentile, Jorge ^b   Sparo, Monica ^b   Barreto, Sergio Menna ^c   Barth, Afonso L ^c   Dias, Cicero ^d   Dos Santos, Breno Riegel ^e   Grenet, Karine ^f   Mounieme, Hyam ^f   Ip, Margaret ^g   Lyon, Donald ^g   Roberts, Sally A ^h   Drinkovic, Dragana ^h   Taylor, Susan L ^h   Von Gottberg, Anne ⁱ   Poswa, Xoliswa ⁱ   Morar, Rajen ⁱ   Gallego, Miquel ^j   Lujan, M ^j   Diaz, Emili ^j   Mariscal, Dolors ^j   Fontanals, Dionisia ^j   Santamaria, Jose M ^j   Rylander, Margareta ^k   Chang, Feng Yee ^l   Wu, Wen Pin ⁿ   Yi, Chia ⁿ   Barefoot, Laurie ^o   McDermott, Laura ^o   Blazes, David L ^p   Marin, Gregory ^p   Mobasseri, Mandana ^q   Kim, Dong Hoon Daniel ^r   Rihs, John D ^r   more..

^a Hospital de Clinicas   (Argentina)

^b Hospital Santmarina   (Argentina)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d S Casa Misericordia de Porto Alegre ^*

^e Hospital da Crianca Conceicao   (Brazil)

^f BICHAT HOSPITAL   (France)

^g CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^h AUCKLAND CITY HOSPITAL   (New Zealand)

ⁱ UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^j HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^k KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^l TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^m NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

ⁿ ST MARTIN DE PORRES HOSPITAL   (Taiwan)

^o TUFTS MEDICAL CENTER   (United States)

^p WALTER REED ARMY MEDICAL CENTER   (United States)

^q UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^r UNIVERSITY OF PITTSBURGH   (United States)

^s VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

Bacteremia; Community acquired pneumonia; Streptococcus pneumoniae

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; VANCOMYCIN;

ADD ON THERAPY; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MONOTHERAPY; MORTALITY; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; CRITICAL CARE; CRITICAL ILLNESS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 4544244010     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200311-1578OC     Document Type: Article

References (16)

1. Macfarlane J. Severe pneumonia and a second antibiotic. Lancet 2002;359:1170-1172.
2. Macfarlane JT, Boswell T, Douglas G, Finch R, Holmes W, Honeybourne D. British Thoracic Society guidelines for the management of community acquired pneumonia in adults. Thorax 2001;56:1-64.
3. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, et al. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730-1754.
4. Barlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000;31:347-382.
5. Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH, Canadian Community-acquired Pneumonia Working Group. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000;31:383-421.
6. Mufson MA, Stanek RJ. Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978-1997. Am J Med 1999; 107:34S-43S.
7. Waterer GW, Somes GW, Wunderick RG. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 2001;161:1837-1842.
8. Martinez JA, Horcajada JP, Almela M, Marco F, Soriano A, Garcia E, Marco MA, Torres A, Mensa J. Addition of a macrolide to a B-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2003;36:389-395.
9. File TM Jr, Mandell LA. What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia? Clin Infect Dis 2003;36:396-398.
10. Yu VL, Chiou CC, Feldman C, Ortqvist A, Rello J, Morris AJ, Baddour LM, Luna CM, Snydman DR, Ip M, Ko WC, Chedid MB, Andremont A, Klugman KP, International Pneumococcal Study Group. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003;37:230-237.
11. Paterson DL, Ko WC, Von Gottberg A, Trenholme G, Klugman KP, Bonomo R, Rice LB, Wagener MW, McCormack JG, Yu VL. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum-β- lactamase production in nosocomial infections. Ann Intern Med 2004;140:2632.
12. Miller LH. Survival analysis. Chapter 5. New York: John Wiley & Sons; 1981.
13. NCCLS. Performance standards for antimicrobial susceptibility testing: twelfth informational supplement. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002. NCCLS Document M100 S12.
14. Kalin M, Ortqvist A, Almela M, Aufwerber E, Dwyer R, Henriques B, Jorup C, Julander I, Marrie TJ, Mufson MA, Riquelme R, Thalme A, Torres A, Woodhead MA. Prospective study of prognostic factors in community-acquired bacteremia pneumococcal disease in 5 countries. J Inject Dis 2000;182:840-847.
15. Brown RB, Iannini P, Gross P, Kunkel M. Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database. Chest 2003;123:1503-1511.
16. Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964;60:759.